Matthew Haney
University of North Carolina at Chapel Hill
H-index: 17
North America-United States
Top articles of Matthew Haney
Poly (2‐oxazoline)‐Based Polyplexes as a PEG‐Free Plasmid DNA Delivery Platform
Macromolecular Bioscience
2023/11
Extracellular Vesicles Released by Genetically Modified Macrophages Activate Autophagy and Produce Potent Neuroprotection in Mouse Model of Lysosomal Storage Disorder, Batten …
Cells
2023/5/29
Biological agent-exosome compositions and uses thereof
2022/12/29
Synthetically functionalized living cells for targeted drug delivery
2022/8/2
Using extracellular vesicles released by GDNF-Transfected macrophages for therapy of Parkinson disease
Cells
2022/6/15
GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic …
Journal of controlled release
2019/12/10
Corrigendum to" GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's …
Journal of controlled release: official journal of the Controlled Release Society
2022/3
Biodistribution of biomimetic drug carriers, mononuclear cells, and extracellular vesicles, in nonhuman primates
Advanced biology
2022/2
Corrigendum to" Exosomes as drug delivery vehicles for Parkinson's disease therapy"[Journal of Controlled Release 207,(2015) 18-30]
Journal of controlled release: official journal of the Controlled Release Society
2021/11/10
Brain targeting and toxicological assessment of the extracellular vesicle-packaged antioxidant catalase-SKL following intranasal administration in mice
Neurotoxicity Research
2021/10
Mannosylated cationic copolymers for gene delivery to macrophages
Macromolecular bioscience
2021/4
Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy
Journal of neuroimmune pharmacology
2020/9
Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X (A) mice: importance of administration routes
Scientific Reports
2020/7/16
Extracellular vesicles as drug carriers for enzyme replacement therapy to treat CLN2 Batten disease: optimization of drug administration routes
Cells
2020/5/20
Extracellular vesicles as drug delivery vehicles for lysosomal enzyme TPP1 to treat Batten disease
Molecular Genetics and Metabolism
2020/2/1